Syntara (ASX:SNT) Accounts Payable : A$4.23 Mil (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Syntara Accounts Payable?

Syntara's Accounts Payable for the quarter that ended in Dec. 2023 was A$4.23 Mil.

Syntara's quarterly Accounts Payable declined from Dec. 2022 (A$3.15 Mil) to Jun. 2023 (A$1.58 Mil) but then increased from Jun. 2023 (A$1.58 Mil) to Dec. 2023 (A$4.23 Mil).

Syntara's annual Accounts Payable declined from Jun. 2021 (A$1.24 Mil) to Jun. 2022 (A$0.62 Mil) but then increased from Jun. 2022 (A$0.62 Mil) to Jun. 2023 (A$1.58 Mil).

Syntara Accounts Payable Historical Data

The historical data trend for Syntara's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syntara Accounts Payable Chart

Syntara Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Accounts Payable

Get a 7-Day Free Trial

1.76

1.24

0.62

1.58

0.61

Syntara Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable	Get a 7-Day Free Trial															0.62	3.15	1.58	4.23	0.61

Syntara Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Syntara Accounts Payable Related Terms

Thank you for viewing the detailed overview of Syntara's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Syntara Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syntara Ltd (ASX:SNT) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

UUDA:Germany

Address

20 Rodborough Road, Unit 2, Frenchs Forest, Sydney, NSW, AUS, 2086

Website

https://www.syntaratx.com.au

Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring, and neuroinflammation.